Nombre del producto:(9AR)-Octahydropyrazino[2,1-c][1,4]oxazine

IUPAC Name:(9aR)-octahydropyrazino[2,1-c][1,4]oxazine

CAS:508241-14-3
Fórmula molecular:C7H14N2O
Pureza:97%
Número de catálogo:CM168932
Peso molecular:142.2

Unidad de embalaje Stock disponible Precio($) Cantidad
CM168932-100mg in stock ůůů
CM168932-250mg 1-2 Weeks ľIJIJIJ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :508241-14-3
Fórmula molecular:C7H14N2O
Punto de fusión:-
Código de sonrisas:[H][C@@]12COCCN1CCNC2
Densidad:
Número de catálogo:CM168932
Peso molecular:142.2
Punto de ebullición:
Nº Mdl:MFCD18830120
Almacenamiento:

Category Infos

Piperazines
Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.
Morpholines
Morpholine contains secondary amine groups and has all the typical reactive characteristics of secondary amine groups. It can react with inorganic acids to form salts, and react with organic acids to form salts or amides, which can be subjected to alkylation reaction, and can also be reacted with ethylene oxide, ketone or Willgerodt reaction. Morpholine is a six-membered ring containing oxygen and nitrogen, and its alkalinity is much lower than that of its parent piperidine. The marketed morpholine drugs are mainly distributed in the fields of tumors, cardiovascular and cerebrovascular diseases, respiratory system diseases, digestive system diseases, infectious diseases and mental disorders.
morpholine price
if you are interested in morpholine price, please feel free to contact us. More information of our products will be forwarded to you upon receipt of your specific inquiry.